A two-arm, randomized, double-blind, placebo-controlled trial to investigate the efficacy and safety of Everolimus (mTOR inhibitor) in pediatric patients with tuberous sclerosis and epilepsy requiring anticonvulsant treatments

View Statistics Email Alert RSS Feed

Grant Data
Project Title
A two-arm, randomized, double-blind, placebo-controlled trial to investigate the efficacy and safety of Everolimus (mTOR inhibitor) in pediatric patients with tuberous sclerosis and epilepsy requiring anticonvulsant treatments
Principal Investigator
Professor Chan, Godfrey Chi Fung   (Principal Investigator (PI))
Co-Investigator(s)
Professor Khong Pek Lan   (Co-Investigator)
Dr Yung Ada Wing Yan   (Co-Investigator)
Duration
24
Start Date
2015-09-01
Completion Date
2019-04-16
Amount
1008920
Conference Title
A two-arm, randomized, double-blind, placebo-controlled trial to investigate the efficacy and safety of Everolimus (mTOR inhibitor) in pediatric patients with tuberous sclerosis and epilepsy requiring anticonvulsant treatments
Keywords
anticonvulsant, epilepsy, mTOK inhibition, tuberous sclerosis
Discipline
Others - Medicine, Dentistry and Health
HKU Project Code
02131526
Grant Type
Health and Medical Research Fund - Full Grant
Funding Year
2014
Status
Completed
Objectives
Please refer to hard copy